ABELCET Side Effects

6988648-1 | Ecchymosis, Hypertensive Crisis
on Sep 01, 2010 Female patient from UNITED STATES , 68 years of age, was diagnosed with candidiasis and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: ecchymosis, hypertensive crisis. Abelcet dosage: 15 Mg; X1; Iv. Patient was hospitalized.

6955949-2 | Acute Respiratory Failure, Atrial Fibrillation, Coagulopathy, Dialysis, Febrile Neutropenia, Liver Disorder, Multi-organ Failure, Renal Failure Acute, Septic Shock
Patient was taking Abelcet (View Usage). Patient had the following side effects: acute respiratory failure, atrial fibrillation (What is atrial fibrillation?), coagulopathy, dialysis (What is dialysis?), febrile neutropenia, liver disorder, multi-organ failure, renal failure acute, septic shock on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 51 years of age, weighting 227.1 lb, was diagnosed with fungal infection (What is fungal infection?), acute myeloid leukaemia and. Abelcet dosage: 500mg Daily Iv. During the same period patient was treated with AMBISOME (291mg Daily Iv) (View Ambisome Review and Ambisome Label ), CYTARABINE (2 Gm Vial 4000mg) (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized.

6823198-4 | Gamma-glutamyltransferase Increased, Haemorrhage Intracranial, Haemorrhagic Diathesis, Thrombocytopenia
Adverse event was reported on Jun 22, 2010 by a Female patient taking Abelcet (View Usage) (Dosage: 5 Mg/kg; Qd; Iv) was diagnosed with fungal infection (What is fungal infection?), sepsis (What is sepsis?), pneumonia (What is pneumonia?) and. Location: UNITED STATES , weighting 3.24 lb, After Abelcet was administered, patient had the following side effects: gamma-glutamyltransferase increased, haemorrhage intracranial, haemorrhagic diathesis, thrombocytopenia. During the same period patient was treated with MEROPENEM (30 Mg; Tid; Iv) (View Meropenem Review and Meropenem Label ), TARGOCID (8 Mg; Qd; Iv) (View Targocid Review and Targocid Label ), PERFALGAN (PARACETAMOL) (7.5 Mg; Tid; Iv) (View Perfalgan (paracetamol) Review and Perfalgan (paracetamol) Label ), PARENTERAL (View Parenteral Review and Parenteral Label ). Patient was hospitalized.

6798385-4 | Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Injury
on Jun 09, 2010 Male patient from UNITED STATES , weighting 5.29 lb, was diagnosed with infection (What is infection?) and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver injury. Abelcet dosage: 5 Mg/kg;qd;iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ).


6755285-3 | Blood Pressure Increased, Chills, Heart Rate Increased, Oxygen Saturation Decreased
on May 20, 2010 Male patient from IRELAND , 73 years of age, weighting 198.4 lb, was diagnosed with prophylaxis and was treated with Abelcet (View Usage). Patient had the following side effects: blood pressure increased, chills, heart rate increased, oxygen saturation decreased. Abelcet dosage: 450 Mg;bid;iv. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), NULYTELY (View Nulytely Review and Nulytely Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), NORADRENALINE (View Noradrenaline Review and Noradrenaline Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), INSULIN (View Insulin Review and Insulin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6755284-1 | Ecchymosis, Hypertensive Crisis
Patient was taking Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: ecchymosis, hypertensive crisis on May 14, 2010 from ITALY Additional patient health information: Female patient , 68 years of age, was diagnosed with candidiasis and. Abelcet dosage: 15 Mg;x1;iv. Patient was hospitalized.

6637691-0 | Erythema, Hypertension, Infusion Related Reaction, Secretion Discharge, Sinus Tachycardia, Tremor
Adverse event was reported on Mar 02, 2010 by a Male patient taking Abelcet (View Usage) (Dosage: 500 Mg; Qd;iv) was diagnosed with pneumonia fungal and. Location: UNITED STATES , 51 years of age, Patient experienced the following unwanted or unexpected effects: erythema, hypertension, infusion related reaction, secretion discharge, sinus tachycardia, tremor. During the same period patient was treated with ROVAMYCIN (View Rovamycin Review and Rovamycin Label ), PENICILLIN G (View Penicillin G Review and Penicillin G Label ), NORADRENALIN (View Noradrenalin Review and Noradrenalin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), HUMULIN R (View Humulin R Review and Humulin R Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), AMINOPHYLLINE (View Aminophylline Review and Aminophylline Label ).

6572001-9 | Bronchospasm, Hypertension, Pyrexia, Tachycardia, Tachypnoea
on Jan 22, 2010 Male patient from IRELAND , 82 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Abelcet (View Usage). Patient had the following side effects: bronchospasm, hypertension, pyrexia, tachycardia, tachypnoea. Abelcet dosage: 400 Mg; Qd; Iv.

6502103-4 |
on Dec 03, 2009 Male patient from UNITED STATES , 67 years of age, was diagnosed with mucormycosis and was treated with Abelcet (View Usage). . Abelcet dosage: Iv. During the same period patient was treated with POSACONAZOLE (View Posaconazole Review and Posaconazole Label ), PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ). Patient was hospitalized.

6499810-9 | Blood Creatinine Increased, Congestive Cardiomyopathy, Dilatation Ventricular, Dyspnoea, Ejection Fraction Decreased, Heart Sounds Abnormal, Left Atrial Dilatation, Osteomyelitis
Patient was taking Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, congestive cardiomyopathy, dilatation ventricular, dyspnoea, ejection fraction decreased, heart sounds abnormal, left atrial dilatation, osteomyelitis on Feb 04, 2004 from UNITED STATES Additional patient health information: Male patient , 20 years of age, weighting 127.9 lb, was diagnosed with coccidioidomycosis and. Abelcet dosage: 290 Mg, Qd, Iv. During the same period patient was treated with AMBISOME (45 Mg, Qd, Iv) (View Ambisome Review and Ambisome Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6463949-4 | Cardiotoxicity, Infusion Related Reaction, Lung Infiltration, Pulmonary Toxicity, Rales, Respiratory Distress
Adverse event was reported on Nov 30, 2009 by a Female patient taking Abelcet (View Usage) (Dosage: 300 Milligrams, Iv) was diagnosed with antifungal treatment, febrile neutropenia and. Location: UNITED STATES , weighting 121.3 lb, Patient had the following side effects: cardiotoxicity, infusion related reaction, lung infiltration, pulmonary toxicity, rales, respiratory distress. During the same period patient was treated with MITOXANTRONE (View Mitoxantrone Review and Mitoxantrone Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMTHEASONE (View Dexamtheasone Review and Dexamtheasone Label ), DIPHENHYDRAMINE HCL (View Diphenhydramine Hcl Review and Diphenhydramine Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6441531-2 | Chills, Cyanosis, Headache, Hypotension, Infusion Related Reaction, Malaise, Nausea, Pain, Pyrexia
on Oct 28, 2009 Male patient from LEBANON , child 11 years of age, was diagnosed with antifungal prophylaxis and was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: chills, cyanosis, headache (What is headache?), hypotension, infusion related reaction, malaise, nausea (What is nausea?), pain (What is pain?), pyrexia. Abelcet dosage: 5 Mg/kg; Iv. During the same period patient was treated with TARGOCID (View Targocid Review and Targocid Label ), BACTRIM (View Bactrim Review and Bactrim Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ). Patient was hospitalized.

6329925-7 | Chills, Pyrexia, Tremor
on Aug 11, 2009 Female patient from POLAND , 14 years of age, weighting 110.2 lb, was diagnosed with pulmonary mycosis and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: chills, pyrexia, tremor. Abelcet dosage: 5 Mg/kg; Qd; Iv. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), ZYVOXID (View Zyvoxid Review and Zyvoxid Label ), POLPRAZOL (View Polprazol Review and Polprazol Label ).

6287581-0 | Blood Bicarbonate Decreased, Bronchopulmonary Aspergillosis, Cardio-respiratory Arrest, Cerebral Toxoplasmosis, Convulsion, Diabetes Insipidus, Disease Progression
Patient was taking Abelcet (View Usage). Patient had the following side effects: blood bicarbonate decreased, bronchopulmonary aspergillosis, cardio-respiratory arrest, cerebral toxoplasmosis, convulsion, diabetes insipidus (What is diabetes insipidus?), disease progression on Jul 17, 2009 from UNITED STATES Additional patient health information: Female patient , 18 years of age, was diagnosed with bronchopulmonary aspergillosis, diabetes insipidus (What is diabetes insipidus?) and. Abelcet dosage: 250 Mg. During the same period patient was treated with AMBISOME (500 Mg) (View Ambisome Review and Ambisome Label ), POSACONAZOLE (200 Mg; Q6h; Po) (View Posaconazole Review and Posaconazole Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), MICAFUNGIN (100 Mg; Qd) (View Micafungin Review and Micafungin Label ), HYDROCHLOROTHIAZIDE (25 Mg; Qd; Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6287424-5 | Body Temperature Increased, Chills, Heart Rate Increased, Hypertension
Adverse event was reported on Jul 13, 2009 by a Male patient taking Abelcet (View Usage) (Dosage: 400 Mg; Qd; Iv) was diagnosed with fungal infection (What is fungal infection?) and. Location: IRELAND , 40 years of age, After Abelcet was administered, patient had the following side effects: body temperature increased, chills, heart rate increased, hypertension. During the same period patient was treated with CLEXANE (View Clexane Review and Clexane Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), MORPHINE (View Morphine Review and Morphine Label ), METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), COMBIVENT (View Combivent Review and Combivent Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6259391-1 | Blood Bicarbonate Decreased, Blood Pressure Increased, Cardio-respiratory Arrest, Convulsion, Heart Rate Decreased, Hypokalaemia, Lymphadenopathy
on Jun 29, 2009 Female patient from UNITED STATES , 18 years of age, was diagnosed with bronchopulmonary aspergillosis, diabetes insipidus (What is diabetes insipidus?) and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood bicarbonate decreased, blood pressure increased, cardio-respiratory arrest, convulsion, heart rate decreased, hypokalaemia, lymphadenopathy. Abelcet dosage: 250 Mg. During the same period patient was treated with AMPHOTERICIN B (500 Mg) (View Amphotericin B Review and Amphotericin B Label ), POSACONAZOLE (200 Mg; Q6h; Po) (View Posaconazole Review and Posaconazole Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), MICAFUNGIN (100 Mg; Qd) (View Micafungin Review and Micafungin Label ), HYDROCHLOROTHIAZIDE (25 Mg; Qd; Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), PYRIMETHAMINE (View Pyrimethamine Review and Pyrimethamine Label ), SULFADIAZINE (View Sulfadiazine Review and Sulfadiazine Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ). Patient was hospitalized.

6237790-1 | Chills, Pyrexia, Tremor
on Jun 05, 2009 Female patient from POLAND , 14 years of age, weighting 110.2 lb, was diagnosed with pulmonary mycosis and was treated with Abelcet (View Usage). Patient had the following side effects: chills, pyrexia, tremor. Abelcet dosage: 5 Mg/kg; Qd; Iv. During the same period patient was treated with CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), PYRALGIN (View Pyralgin Review and Pyralgin Label ).

6235234-7 | Body Temperature Increased, Chills, Heart Rate Increased, Hypertension
Patient was taking Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: body temperature increased, chills, heart rate increased, hypertension on Jun 04, 2009 from UNITED STATES Additional patient health information: Male patient , 40 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Abelcet dosage: 400 Mg; Qd; Iv. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), MORPHINE (View Morphine Review and Morphine Label ), METHADONE (View Methadone Review and Methadone Label ), COMBIVENT (View Combivent Review and Combivent Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

6219115-0 | Oxygen Saturation Decreased, Tachycardia
Adverse event was reported on May 25, 2009 by a Male patient taking Abelcet (View Usage) (Dosage: ) . Location: UNITED STATES , 75 years of age, Patient experienced the following unwanted or unexpected effects: oxygen saturation decreased, tachycardia.

6175439-7 | Rhabdomyolysis
on Apr 16, 2009 Male patient from UNITED STATES , 35 years of age, weighting 144.0 lb, was diagnosed with meningitis (What is meningitis?), convulsion prophylaxis and was treated with Abelcet (View Usage). Patient had the following side effects: rhabdomyolysis. Abelcet dosage: 340 Mg; Qd; Iv. During the same period patient was treated with DILANTIN (300 Mg; Qd; Po) (View Dilantin Review and Dilantin Label ), DEPAKOTE (250 Mg; Tid; Po) (View Depakote Review and Depakote Label ), VERSED (View Versed Review and Versed Label ), PROPOFOL (View Propofol Review and Propofol Label ), TYLENOL (View Tylenol Review and Tylenol Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), ATRIPLA (View Atripla Review and Atripla Label ), ENALAPRILAT (View Enalaprilat Review and Enalaprilat Label ). Patient was hospitalized.

6159213-3 | Blood Pressure Decreased, Chills, Tachycardia
on Apr 01, 2009 Male patient from IRELAND , 48 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: blood pressure decreased, chills, tachycardia. Abelcet dosage: 450 Mg; Qd; Iv. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CLEXANE (View Clexane Review and Clexane Label ), PABRINEX (View Pabrinex Review and Pabrinex Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), TAZOCIN (View Tazocin Review and Tazocin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ).

6147122-5 | Blood Pressure Increased, Oxygen Saturation Decreased, Pyrexia, Tachycardia
Patient was taking Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, oxygen saturation decreased, pyrexia, tachycardia on Mar 23, 2009 from IRELAND Additional patient health information: Male patient , 48 years of age, was diagnosed with respiratory disorder, sepsis (What is sepsis?) and. Abelcet dosage: 450 Mg; Qd; Iv. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), MORPHINE (View Morphine Review and Morphine Label ), COMBIVENT (View Combivent Review and Combivent Label ), TAXOCIN (View Taxocin Review and Taxocin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ).

6084770-5 | Bradycardia, Hyperkalaemia, Ventricular Fibrillation
Adverse event was reported on Feb 03, 2009 by a Male patient taking Abelcet (View Usage) (Dosage: 375 Mg;qd;iv) was diagnosed with aspergillosis, pneumonia (What is pneumonia?), sepsis (What is sepsis?), zygomycosis and. Location: NETHERLANDS , 36 years of age, Patient had the following side effects: bradycardia, hyperkalaemia, ventricular fibrillation. During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

6076492-1 | Hallucination, Nausea, Pruritus, Pyrexia, Rash
on Jan 28, 2009 Female patient from UNITED STATES , child 10 years of age, was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: hallucination, nausea (What is nausea?), pruritus, pyrexia, rash (What is rash?). Abelcet dosage: 190 Mg; Qd; Iv. During the same period patient was treated with VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), CEFTAZIDIME (View Ceftazidime Review and Ceftazidime Label ), CO TRIMOXAZOLE (View Co-trimoxazole Review and Co-trimoxazole Label ).

6066275-0 | Blood Pressure Increased, Hypersensitivity, Lung Disorder, Oxygen Saturation Decreased
on Jan 20, 2009 Male patient from IRELAND , 67 years of age, was diagnosed with candida sepsis and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, hypersensitivity, lung disorder, oxygen saturation decreased. Abelcet dosage: 350 Mg;qd;iv.

6065771-X | Blood Pressure Increased, Heart Rate Increased, Hyperhidrosis, Restlessness
Patient was taking Abelcet (View Usage). Patient had the following side effects: blood pressure increased, heart rate increased, hyperhidrosis, restlessness on Jan 21, 2009 from IRELAND Additional patient health information: Female patient , 72 years of age, was diagnosed with sepsis (What is sepsis?) and. Abelcet dosage: 385 Mg; Qd; Iv. During the same period patient was treated with FENTANYL 75 (View Fentanyl-75 Review and Fentanyl-75 Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ).

6052295-9 | Blood Pressure Increased, Heart Rate Increased, Hyperventilation, Tremor
Adverse event was reported on Jan 09, 2009 by a Male patient taking Abelcet (View Usage) (Dosage: 240 Mg; ; Iv) was diagnosed with systemic candida and. Location: IRELAND , 53 years of age, After Abelcet was administered, patient had the following side effects: blood pressure increased, heart rate increased, hyperventilation, tremor. During the same period patient was treated with LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), CHLORPROMAZINE (View Chlorpromazine Review and Chlorpromazine Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ).

6036293-7 | Thrombocytopenia
on Aug 15, 2008 Male patient from UNITED STATES , 53 years of age, weighting 154.3 lb, was diagnosed with meningitis cryptococcal and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: thrombocytopenia. Abelcet dosage: 350 Mg; Qd; Iv. During the same period patient was treated with ONCOVIN (View Oncovin Review and Oncovin Label ). Patient was hospitalized.

6028857-1 | Hypertension, Tremor
on Dec 22, 2008 Female patient from IRELAND , 53 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Abelcet (View Usage). Patient had the following side effects: hypertension, tremor. Abelcet dosage: 225 Mg; Qd; Iv.

6015057-4 | Chills, Peripheral Coldness, Pyrexia, Tachycardia
Patient was taking Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: chills, peripheral coldness, pyrexia, tachycardia on Dec 04, 2008 from UNITED STATES Additional patient health information: Female patient , 17 years of age, was diagnosed with aspergillosis and. Abelcet dosage: 200 Mg; Qd; Iv. During the same period patient was treated with ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ).

6012723-1 | Chills, Oxygen Saturation Decreased, Peripheral Coldness, Pyrexia
Adverse event was reported on Dec 04, 2008 by a Male patient taking Abelcet (View Usage) (Dosage: 150 Mg; Qd; Iv) was diagnosed with aspergillosis and. Location: POLAND , child 8 years of age, Patient experienced the following unwanted or unexpected effects: chills, oxygen saturation decreased, peripheral coldness, pyrexia. During the same period patient was treated with CEFEPIME (View Cefepime Review and Cefepime Label ), LINEZOLID (View Linezolid Review and Linezolid Label ).

6012589-X | Chills, Hypotension, Peripheral Coldness, Pyrexia
on Dec 04, 2008 Male patient from UNITED STATES , 14 years of age, was treated with Abelcet (View Usage). Patient had the following side effects: chills, hypotension, peripheral coldness, pyrexia. Abelcet dosage: 200 Mg;qd; Iv. During the same period patient was treated with SACCHAROMYCES BOULARDII (View Saccharomyces Boulardii Review and Saccharomyces Boulardii Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), BACTRIM (View Bactrim Review and Bactrim Label ).

6012588-8 | Chills, Hypotension, Peripheral Coldness, Pyrexia
on Dec 04, 2008 Female patient from UNITED STATES , 13 years of age, was diagnosed with aspergillosis and was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: chills, hypotension, peripheral coldness, pyrexia. Abelcet dosage: 300 Mg;qd;iv. During the same period patient was treated with TEICOPLANIN (View Teicoplanin Review and Teicoplanin Label ), TAZOCIN (View Tazocin Review and Tazocin Label ).

5989750-3 | Blood Pressure Increased, Condition Aggravated, Heart Rate Increased, Oxygen Saturation Decreased, Wheezing
Patient was taking Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, condition aggravated, heart rate increased, oxygen saturation decreased, wheezing on Nov 26, 2008 from IRELAND Additional patient health information: Female patient , 71 years of age, was diagnosed with evidence based treatment and. Abelcet dosage: 350 Mg; Iv. During the same period patient was treated with MEROPENEM (View Meropenem Review and Meropenem Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), COMBIVENT (View Combivent Review and Combivent Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MORPHINE (View Morphine Review and Morphine Label ).

5989425-0 | Blood Pressure Increased, Heart Rate Increased, Hyperhidrosis, Restlessness
Adverse event was reported on Nov 26, 2008 by a Female patient taking Abelcet (View Usage) (Dosage: 385 Mg; Qd; Iv) was diagnosed with sepsis (What is sepsis?) and. Location: UNITED STATES , 72 years of age, Patient had the following side effects: blood pressure increased, heart rate increased, hyperhidrosis, restlessness. During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CIPROFLOXACIN HCL (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), AMIKACIN (View Amikacin Review and Amikacin Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), COMBIVENT (View Combivent Review and Combivent Label ).

5988219-X | Bronchospasm, Chills, Dyspnoea, Infusion Related Reaction, Tachycardia, Tachypnoea
on Nov 24, 2008 Female patient from UNITED STATES , 70 years of age, was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: bronchospasm, chills, dyspnoea, infusion related reaction, tachycardia, tachypnoea. Abelcet dosage: 20 Mg; Iv.

5912747-6 | Hypertension, Tachycardia, Tachypnoea
on Sep 24, 2008 Male patient from IRELAND , 63 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, tachycardia, tachypnoea. Abelcet dosage: 400 Mg X1 Iv. During the same period patient was treated with OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DOBUTAMINE HCL (View Dobutamine Hcl Review and Dobutamine Hcl Label ), HYDROCHLORIDE (View Hydrochloride Review and Hydrochloride Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), MEROPENEM (View Meropenem Review and Meropenem Label ).

5900839-7 | Blood Pressure Increased, Body Temperature Increased, Chills, Oxygen Saturation Decreased, Respiratory Rate Increased
Patient was taking Abelcet (View Usage). Patient had the following side effects: blood pressure increased, body temperature increased, chills, oxygen saturation decreased, respiratory rate increased on Sep 19, 2008 from IRELAND Additional patient health information: Male patient , 30 years of age, was diagnosed with evidence based treatment and. Abelcet dosage: 450 Mg;qd;iv. During the same period patient was treated with NYSTAFORM (View Nystaform Review and Nystaform Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), MORPHINE (View Morphine Review and Morphine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COMBIVENT (View Combivent Review and Combivent Label ), HEPARIN (View Heparin Review and Heparin Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), MERONEM (View Meronem Review and Meronem Label ).

5893464-8 | Blood Pressure Increased, Body Temperature Increased, Chills, Oxygen Saturation Decreased, Respiratory Rate Increased
Adverse event was reported on Sep 09, 2008 by a Male patient taking Abelcet (View Usage) (Dosage: 450 Mg; Qd; Iv) was diagnosed with evidence based treatment and. Location: IRELAND , 30 years of age, After Abelcet was administered, patient had the following side effects: blood pressure increased, body temperature increased, chills, oxygen saturation decreased, respiratory rate increased. During the same period patient was treated with NYSTAFORM (View Nystaform Review and Nystaform Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), MORPHINE (View Morphine Review and Morphine Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COMBIVENT (View Combivent Review and Combivent Label ), HEPARIN (View Heparin Review and Heparin Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ), MERONEM (View Meronem Review and Meronem Label ).

5893100-0 | Blood Pressure Increased, Oxygen Saturation Decreased, Respiratory Rate Increased
on Sep 09, 2008 Male patient from IRELAND , 33 years of age, was diagnosed with evidence based treatment and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, oxygen saturation decreased, respiratory rate increased. Abelcet dosage: 350 Mg; Qd; Iv. During the same period patient was treated with NYSTAFORM (View Nystaform Review and Nystaform Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ENOXAPARIN (View Enoxaparin Review and Enoxaparin Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ).

5874794-2 | Blood Pressure Systolic Decreased, Body Temperature Increased, Chills, Oxygen Saturation Decreased, Respiratory Rate Increased
on Aug 22, 2008 Female patient from IRELAND , 61 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Abelcet (View Usage). Patient had the following side effects: blood pressure systolic decreased, body temperature increased, chills, oxygen saturation decreased, respiratory rate increased. Abelcet dosage: 450 Mg; Qd; Iv, 500 Mg; Qd; Iv. During the same period patient was treated with CHLORPHENAMINE (View Chlorphenamine Review and Chlorphenamine Label ), VANCOMYCIN HYDROCHLORIDE (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), PREGABALIN (View Pregabalin Review and Pregabalin Label ), FERROUS FUMARATE (View Ferrous Fumarate Review and Ferrous Fumarate Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ).

5873985-4 | Deafness, Ototoxicity
Patient was taking Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: deafness, ototoxicity on Sep 05, 2008 from UNITED STATES Additional patient health information: Male patient , 33 years of age, weighting 185.2 lb, was diagnosed with meningitis cryptococcal and. Abelcet dosage: 430mg Daily Iv. During the same period patient was treated with ZOFRAN (View Zofran Review and Zofran Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

5859223-7 | Blood Pressure Increased, Oxygen Saturation Decreased, Respiratory Rate Increased
Adverse event was reported on Aug 13, 2008 by a Male patient taking Abelcet (View Usage) (Dosage: 350 Mg; Qd; Iv) was diagnosed with evidence based treatment and. Location: UNITED STATES , 33 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure increased, oxygen saturation decreased, respiratory rate increased. During the same period patient was treated with NYSTAFORM (View Nystaform Review and Nystaform Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), IPRATROPIUM BROMIDE (View Ipratropium Bromide Review and Ipratropium Bromide Label ), GLUTAMINE (View Glutamine Review and Glutamine Label ), MEROPENEM (View Meropenem Review and Meropenem Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), METOCLOPRAMINE (View Metoclopramine Review and Metoclopramine Label ).

5810566-2 | Anaphylactic Reaction
on Jun 26, 2008 Male patient from GERMANY , 59 years of age, was diagnosed with bronchopulmonary aspergillosis, sepsis (What is sepsis?) and was treated with Abelcet (View Usage). Patient had the following side effects: anaphylactic reaction. Abelcet dosage: Iv. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ANTIHISTAMINE (View Antihistamine Review and Antihistamine Label ), CORTISONE (View Cortisone Review and Cortisone Label ), MOXIFLOXACIN HCL (View Moxifloxacin Hcl Review and Moxifloxacin Hcl Label ), ANTIHYPERTENSIVE (View Antihypertensive Review and Antihypertensive Label ), ANTIARRHYTHMIC (View Antiarrhythmic Review and Antiarrhythmic Label ), VOLUME/ BLOOD PLASMA/ ERYTHROCYTE CONCENTRATION ^HEMOFILTRATIONSLOESNI (View Volume/ Blood Plasma/ Erythrocyte Concentration ^hemofiltrationsloesni Review and Volume/ Blood Plasma/ Erythrocyte Concentration ^hemofiltrationsloesni Label ). Patient was hospitalized.

5732100-8 | Atrial Fibrillation
on Apr 24, 2008 Male patient from UNITED STATES , 35 years of age, was diagnosed with aspergillosis and was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: atrial fibrillation (What is atrial fibrillation?). Abelcet dosage: 300 Mg;qd;iv. During the same period patient was treated with NEFOPAM (View Nefopam Review and Nefopam Label ), HEPARIN (View Heparin Review and Heparin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ). Patient was hospitalized.

5713136-X | Chills, Dyspnoea, Poor Peripheral Circulation, Pyrexia, Tremor
Patient was taking Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: chills, dyspnoea, poor peripheral circulation, pyrexia, tremor on Apr 04, 2008 from POLAND Additional patient health information: Male patient , child 10 years of age, . Abelcet dosage: 100 Mg; Qd; Iv. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), BACTRIM (View Bactrim Review and Bactrim Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5705805-2 | Bone Marrow Granuloma, Fungus Urine Test Positive, Granulomatous Liver Disease, Histoplasmosis Disseminated, Lymphadenopathy, Pulmonary Granuloma, Splenic Granuloma
Adverse event was reported on Apr 01, 2008 by a Female patient taking Abelcet (View Usage) (Dosage: Iv) was diagnosed with bronchopulmonary aspergillosis, histoplasmosis and. Location: UNITED STATES , 76 years of age, Patient had the following side effects: bone marrow granuloma, fungus urine test positive, granulomatous liver disease, histoplasmosis disseminated, lymphadenopathy, pulmonary granuloma, splenic granuloma. During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), PREDNSONE (View Prednsone Review and Prednsone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5599346-3 | Adrenal Insufficiency, Bradycardia, Hyperkalaemia, Ventricular Fibrillation
on Jan 03, 2008 Male patient from NETHERLANDS , 36 years of age, was diagnosed with pneumococcal sepsis, zygomycosis and was treated with Abelcet (View Usage). After Abelcet was administered, patient had the following side effects: adrenal insufficiency, bradycardia, hyperkalaemia, ventricular fibrillation. Abelcet dosage: 375 Mg; Qd; Iv. During the same period patient was treated with VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), FENTANYL (View Fentanyl Review and Fentanyl Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), INSULIN (View Insulin Review and Insulin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ).

5598460-6 | Convulsion
on Dec 21, 2006 Male patient from UNITED STATES , 70 years of age, was diagnosed with upper respiratory fungal infection and was treated with Abelcet (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Abelcet dosage: ;iv.

5518845-3 | Infusion Related Reaction
Patient was taking Abelcet (View Usage). Patient had the following side effects: infusion related reaction on Oct 30, 2007 from IRELAND Additional patient health information: Male patient , 47 years of age, was diagnosed with candidiasis and. Abelcet dosage: 400 Mg;qd; Iv. During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), LINEZOLID (View Linezolid Review and Linezolid Label ). Patient was hospitalized.